Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTavistock Regulatory News (TAVI)

Share Price Information for Tavistock (TAVI)

Share Price is delayed by 15 minutes
Get Live Data
3.15    0.00 (0.00%)
Bid:
3.00
Ask:
3.30
Spread: 0.30 (10.00%)
Market Cap: £13.89m
TAVI Live PriceLast checked at - London Stock Exchange

Intraday Tavistock Share Chart

Issue of Equity

3 Apr 2009 07:00

RNS Number : 0491Q
Bright Things plc
03 April 2009
 



Bright Things plc

("Bright Things" or the "Company")

Issue of Equity

 

The Directors of Bright Things plc are pleased to announce that the Company has raised £750,500 (before expenses) through the placing of 60,040,000 new ordinary shares of 1 penny each in the capital of the Company ("Ordinary Shares") at 1.25 pence per share ("Placing Price") (the "Placing").

Details of the Placing

Pursuant to the powers granted to the Directors at the Extraordinary General Meeting of the Company, held on 30 March 2009, the 60,040,000 new Ordinary Shares ("Placing Shares") have been conditionally placed by HB Corporate with investors and Directors at a price of 1.25p per share to raise £750,500 (before expenses). The Placing Shares will represent approximately 30.68 per cent. of the Company's enlarged issued share capital following completion of the Placing.

 

The purpose of the funds raised is to provide additional working capital for the Company as it looks to expand the reach and potential market for its SocialGO product. Additionally, it will be used to recruit sales and marketing personnel as well as improving the back office and server capabilities. 

The Placing shares will, when issued and fully paid, rank pari passu in all respects with the existing issued Ordinary Shares. Application has been made for the Placing Shares to be admitted to AIM. The Placing is conditional, inter alia, on the admission of the Placing Shares to AIM becoming effective ("Admission"), which is expected to occur on 8 April 2009, when dealings in the Placing Shares are expected to commence. 

Following Admission the Company will have 195,716,328 Ordinary Shares in issue.

Director Dealing 

Dominic Wheatley (Chief Executive), Charles Delamain, Ian Livingstone  (Chairman) and Edward Levey have subscribed for the following number of Placing Shares pursuant to the Placing:

Director

Number of Placing shares

% of total Placing shares

Dominic Wheatley

4,000,000

6.66

Ian Livingstone

2,800,000

4.66

Charles Delamain

8,000,000

13.32

Edward Levey

240,000

0.4

Immediately following Admission, the Directors will hold interests in the issued ordinary share capital of the Company as follows: 

Director

Total Number of shares in the Company 

% of total issued ordinary share capital 

Dominic Wheatley

28,205,102

14.41

Ian Livingstone

8,105,556

4.14

Charles Delamain

12,000,000

6.13

Edward Levey

240,000

0.12

The issue of Placing Shares to these Directors is classified as a transaction with a related party for the purposes of the AIM Rules. In accordance with the AIM Rules, the Company's Nominated Adviser, HB Corporate, and Matthew Tims, as independent director in respect of this transaction (having consulted with HB Corporate) considers that the terms of the Placing are fair and reasonable insofar as the Company's shareholders are concerned.

For further information please contact:

Bright Things PLC  0845 299 7289

Dominic Wheatley, CEO

Edward Levey, Finance Director

HB Corporate 020 7510 8600

Luke Cairns/ Rory Creedon

Threadneedle Communications 020 7653 9850 Graham Herring  Alex White

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOECKBKNPBKDBQK
Date   Source Headline
29th May 20269:00 amRNSDirectorate Change
2nd Apr 20267:00 amRNSCompletion of Acquisition
30th Mar 20262:55 pmRNSChange of Auditor
5th Feb 20267:00 amRNSFurther Update on Litigation with Titan
20th Jan 20267:00 amRNSAppointment of Nominated Adviser and Broker
23rd Dec 20257:00 amRNSInterim Results
23rd Dec 20257:00 amRNSInterim Results
17th Dec 202512:13 pmRNSFurther update re ongoing litigation with Titan
16th Dec 20257:00 amRNSUpdate re ongoing litigation with Titan
6th Nov 202512:00 pmRNSResult of AGM
2nd Oct 20257:00 amRNSUpdate re ongoing litigation
30th Sep 20255:00 pmRNSTotal Voting Rights
30th Sep 20257:00 amRNSNotice of AGM
25th Sep 20257:00 amRNSTransfer of Shares from treasury to EBT and TVR
24th Sep 202510:57 amRNSDirector/PDMR Shareholding
18th Sep 20257:00 amRNSFinal Results for the Year Ended 31 March 2025
15th Sep 20252:08 pmRNSHolding(s) in Company
11th Sep 20257:00 amRNSStrategic refocus and acquisition of Lifetime
7th Jul 202512:40 pmRNSDirector / PDMR Dealing
8th Apr 20254:15 pmRNSDirector/PDMR Shareholding
12th Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20255:00 pmRNSTotal Voting Rights
20th Feb 20257:00 amRNSCompletion of acquisition of Alpha Beta Partners
14th Feb 202512:08 pmRNSDirector/PDMR Shareholding
11th Feb 20257:00 amRNSTransaction in Own Shares,Director Dealing and TVR
6th Feb 20252:16 pmRNSDirector/PDMR Shareholding
30th Jan 202511:00 amRNSHolding(s) in Company
30th Jan 20259:53 amRNSHolding(s) in Company
6th Jan 202511:54 amRNSHolding(s) in Company
2nd Jan 20255:45 pmRNSTotal Voting Rights - Replacement
31st Dec 20241:30 pmRNSTotal Voting Rights
12th Dec 202412:00 pmRNSTransaction in Own Shares and Total Voting Rights
11th Dec 202411:30 amRNSResult of AGM
9th Dec 202412:49 pmRNSTransaction in Own Shares and Total Voting Rights
9th Dec 20247:00 amRNSInterim Results
2nd Dec 20247:00 amRNSRepositioning of Retail Asset Management business
22nd Nov 20247:00 amRNSStrategic acquisition and completion of disposal
11th Nov 20243:38 pmRNSNotice of AGM
30th Oct 202411:25 amRNSResult of General Meeting
2nd Oct 20243:50 pmRNSPublication of Circular and Notice of GM
2nd Oct 202411:32 amRNSDirector/PDMR Shareholding
1st Oct 20247:00 amRNSProposed disposals for up to £37.75 million
30th Sep 20247:00 amRNSFinal Results for the Year Ended 31 March 2024
19th Sep 20242:47 pmRNSUpdate on Titan Dispute
11th Jul 20247:00 amRNSFollow up to Titan termination announcement
8th Jul 20244:19 pmRNSTermination of strategic partnership
28th Jun 202410:16 amRNSStatement re press speculation
21st Jun 202410:31 amRNSDirectorate Change
31st May 20247:00 amRNSBoard role change
8th Jan 20247:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.